JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB143564

ML297 (VU0456810), GIRK activator

Be the first to review this product! Submit a review

|

(4 Publications)

MW 328.32 Da, Purity >99%. Potent, selective GIRK activator (EC50 = 160 nM). Shows anticonvulsant effects in vivo. .
1 Images
Chemical Structure - ML297 (VU0456810), GIRK activator (AB143564)
  • Chemical Structure

Lab

Chemical Structure - ML297 (VU0456810), GIRK activator (AB143564)

2D chemical structure image of ab143564, ML297 (VU0456810), GIRK activator

Key facts

CAS number

1443246-62-5

Purity

>99%

Form

Solid

form

Molecular weight

328.32 Da

Molecular formula

C<sub>1</sub><sub>7</sub>H<sub>1</sub><sub>4</sub>F<sub>2</sub>N<sub>4</sub>O

PubChem

56642816

Nature

Synthetic

Solubility

Soluble in DMSO to 100 mM

Soluble in ethanol to 50 mM (with warming)

Biochemical name

1-(3,4-difluorophenyl)-3-(3-methyl-1-phenyl-1H-pyrazol-5-yl)urea

Biological description

Potent, selective GIRK activator (EC50 = 160 nM). Shows anticonvulsant effects in vivo.

Canonical smiles

CC1=NN(C(=C1)NC(=O)NC2=CC(=C(C=C2)F)F)C3=CC=CC=C3

InChi

InChI=1S/C17H14F2N4O/c1-11-9-16(23(22-11)13-5-3-2-4-6-13)21-17(24)20-12-7-8-14(18)15(19)10-12/h2-10H,1H3,(H2,20,21,24)

InChiKey

IEKSMUSSYJUQMY-UHFFFAOYSA-N

IUPAC Name

1-(3,4-difluorophenyl)-3-(5-methyl-2-phenylpyrazol-3-yl)urea

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
The product can be stored for up to 12 months

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

GIRK2 also known as KCNJ5 or H-ERG is a potassium channel protein. It conducts potassium ions across cell membranes assisting in the regulation of electrical activity within cells. GIRK2 consists of subunits that form a channel with a mass of approximately 53 kDa. This protein expresses mainly in the brain heart and pancreas playing significant roles in each of these tissues.
Biological function summary

GIRK2 contributes to maintaining the resting membrane potential and modulating neuronal excitability. It forms part of a larger complex by interacting with other proteins such as GIRK1 which aids in its regulation and function. Its activity is primarily modulated by G-proteins which enable it to participate in responding to various cellular signals affecting excitation and inhibition balance within neurons.

Pathways

GIRK2 plays a significant role within the G-protein-coupled receptor (GPCR) signaling pathway. In heart tissue GIRK channels contribute to the parasympathetic regulation of the heart rate by the acetylcholine muscarinic receptors. Furthermore GIRK2 interacts with various signaling molecules like the beta-gamma subunits of G-proteins which modulates the activity of the potassium channel in response to neurotransmitter signals.

GIRK2 has associations with disorders such as cardiac arrhythmias and neuropsychiatric disorders. Mutations or dysregulation in GIRK2 can lead to Long QT Syndrome a cardiac condition related to its role in cardiac repolarization. Its relation to neuropsychiatric disorders stems from its function in the brain where it interacts with proteins like GIRK1 and other ion channels influencing neural health and activity.

Product protocols

Publications (4)

Recent publications for all applications. Explore the full list and refine your search

The Journal of neuroscience : the official journal of the Society for Neuroscience 41:7086-7102 PubMed34261700

2021

G-Protein-Gated Inwardly Rectifying Potassium (Kir3/GIRK) Channels Govern Synaptic Plasticity That Supports Hippocampal-Dependent Cognitive Functions in Male Mice.

Applications

Unspecified application

Species

Unspecified reactive species

Souhail Djebari,Guillermo Iborra-Lázaro,Sara Temprano-Carazo,Irene Sánchez-Rodríguez,Mauricio O Nava-Mesa,Alejandro Múnera,Agnès Gruart,José M Delgado-García,Lydia Jiménez-Díaz,Juan D Navarro-López

Journal of neurochemistry 153:362-376 PubMed31875959

2020

Hippocampal long-term synaptic depression and memory deficits induced in early amyloidopathy are prevented by enhancing G-protein-gated inwardly rectifying potassium channel activity.

Applications

Unspecified application

Species

Unspecified reactive species

Irene Sánchez-Rodríguez,Souhail Djebari,Sara Temprano-Carazo,David Vega-Avelaira,Raquel Jiménez-Herrera,Guillermo Iborra-Lázaro,Javier Yajeya,Lydia Jiménez-Díaz,Juan D Navarro-López

Neuropharmacology 137:1-12 PubMed29689260

2018

Effects of monoamines on the intrinsic excitability of lateral orbitofrontal cortex neurons in alcohol-dependent and non-dependent female mice.

Applications

Unspecified application

Species

Unspecified reactive species

Sudarat Nimitvilai,Marcelo F Lopez,John J Woodward

Biomedicine & pharmacotherapy = Biomedecine & phar 101:362-370 PubMed29499411

2018

GIRK1-mediated inwardly rectifying potassium current suppresses the epileptiform burst activities and the potential antiepileptic effect of ML297.

Applications

Unspecified application

Species

Unspecified reactive species

Yian Huang,Yuwen Zhang,Shuzhen Kong,Kai Zang,Shize Jiang,Li Wan,Lulan Chen,Guoxiang Wang,Min Jiang,Xin Wang,Jie Hu,Yun Wang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com